ChulKimMD

PubMed

• Influence ofComutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in-Mutant Non-Small-Cell Lung Cancer.
  Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao V Alessi, M...> ;JCO Precision Oncology. 2024 Feb 1
• High levels of expression of Trop-2 in thymic epithelial tumors.
  Vincent Yeung, Jacob Zaemes, Justin Yeh, Cardoza Giancarlo, Jaeil Ahn, Joshua E Reuss, Bhaskar V Kallakury, Stephen V Liu, Anju Duttargi, Galam Khan, Chul Kim> ;Lung Cancer. 2023 Oct 1
• 4 citations
  Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset.
  Misako Nagasaka, Danielle Brazel, Yasmine Baca, Joanne Xiu, Mohammed Najeeb Al-Hallak, Chul Kim, Jorge Nieva, Jeffrey J Swensen, David Spetzler, Wolfgang Michael Korn,...> ;Translational Oncology. 2023 Oct 1
• 7 citations
  Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in Pe...
  Dobbs, R. W., Talal El Zarif, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingji...> ;Journal of Clinical Oncology. 2023 Jul 20
• 1 citations
  Integrating Tobacco Use Assessment and Treatment in the Oncology Setting: Quality Improvement Results from the Georgetown Lombardi Smoking Treatment and Recovery Program.
  Kathryn L Taylor, Marguerite A Webster, Joanna G Philips, Julia M Whealan, Tania Lobo, Kimberly M Davis, Chavalia J Breece, Jennifer R Wheeley, Jack E Childs, Ariel Q ...> ;Current Oncology. 2023 Mar 28
• Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer.
  Robert Hsu, Denaly Chen, Bing Xia, Rebecca Feldman, Wendy Cozen, Luis E Raez, Hossein Borghaei, Chul Kim, Misako Nagasaka, Hirva Mamdani, Ari M Vanderwalde, Gilberto L...> ;Frontiers in Oncology. 2023 Jan 1
• 3 citations
  Response to selpercatinib in a patient withfusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report.
  Aakriti Arora, Jacob Zaemes, Metin Ozdemirli, Chul Kim> ;Frontiers in Oncology. 2023 Jan 1
• 3 citations
  Remarkable Intracranial Response to Sotorasib in a Patient With-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case Report.
  Justin Yeh, Jennifer A Marks, Ali H Alzeer, Emily A Sloan, Reshma Varghese, Nitika Paudel, Joshua E Reuss, Peter J Bergquist, Stephen V Liu, Chul Kim> ;JTO Clinical and Research Reports. 2022 Dec 1
• 2 citations
  High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy.
  Michael Carrasquilla, Nitika Paudel, Brian T Collins, Eric Anderson, Rebecca Krochmal, Marc Margolis, Ahssan Balawi, David DeBlois, Giuseppe Giaccone, Chul Kim, Stephe...> ;Advances in Radiation Oncology. 2022 Nov 24
• Use of Erdafitinib in-Mutated Recurrent Respiratory Papillomatosis.
  Vincent Yeung, Paul Sackstein, Nazaneen N Grant, Rebecca Krochmal, Nishant Gandhi, Charu Aggarwal, Balazs Halmos, Joshua E Reuss, Stephen V Liu, Chul Kim> ;JCO Precision Oncology. 2022 Nov 1
• 1 citations
  Osimertinib and Capmatinib Combination Therapy to OvercomeY1003N-Mediated Resistance in-Mutant NSCLC: A Case Report.
  Molly Wilgucki, Vincent Yeung, Grace Ho, Gabriela L Bravo Montenegro, Greg Jones, Joshua E Reuss, Stephen V Liu, Chul Kim> ;JTO Clinical and Research Reports. 2022 Oct 1
• Pembrolizumab-Associated Cutaneous and Pulmonary Sarcoidosis in Non-Small Cell Lung Cancer Treatment.
  Yasmina Sirgi, Rebecca Krochmal, Christine M Fleury, Margaret Holmes, Christine A Dewitt, Michael Cardis, Chul Kim> ;Clinical Lung Cancer. 2022 Sep 1
• 5 citations
  Characterization ofExon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing.
  So Yeon Kim, Jun Yin, Stephen Bohlman, Phillip Walker, Sanja Dacic, Chul Kim, Hina Khan, Stephen V Liu, Patrick C Ma, Misako Nagasaka, Karen L Reckamp, Jim Abraham, Di...> ;JTO Clinical and Research Reports. 2022 Sep 1
• 2 citations
  Race & sex disparities related to low-dose computed tomography lung cancer screening eligibility criteria: A lung cancer cases review.
  Randi M Williams, Samuel A Kareff, Paul Sackstein, Tina Roy, George Luta, Chul Kim, Kathryn L Taylor, Martin C Tammemägi> ;Lung Cancer. 2022 Jul 1
• 3 citations
  Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy.
  Ishani Joshi, Monica Peravali, Xue Geng, Suman Rao, Kevin Y Chen, Irina Veytsman, Giuseppe Giaccone, Stephen V Liu, Chul Kim> ;Clinical Lung Cancer. 2022 Jul 1
• 1 citations
  Use of on-therapy ctDNA monitoring in a patient withfusion positive advanced non-small cell lung cancer: a case report.
  Vincent Yeung, Chul Kim, Lesli A Kiedrowski, Stephen V Liu, Joshua E Reuss> ;Translational Lung Cancer Research. 2022 Jan 1
• 5 citations
  Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.
  Robert Hsu, Yasmine Baca, Joanne Xiu, Rongfu Wang, J Nicholas Bodor, Chul Kim, Hina Khan, Hirva Mamdani, Misako Nagasaka, Sonam Puri, Stephen V Liu, W Michael Korn, Jo...> ;Oncotarget. 2021 Dec 7
• 13 citations
  The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer.
  Misako Nagasaka, Vijendra Singh, Yasmine Baca, Ammar Sukari, Chul Kim, Hirva Mamdani, Alexander I. Spira, Dipesh Uprety, Gerold Bepler, Edward S. Kim, Luis E. Raez, Sa...> ;Clinical Lung Cancer. 2021 Oct 18
• 55 citations
  Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer.
  Julia Judd, Nagla Abdel Karim, Hina Khan, Abdul Rafeh Naqash, Yasmine Baca, Joanne Xiu, Ari M. Vanderwalde, Hirva Mamdani, Luis E. Raez, Misako Nagasaka, Sachin Gopalk...> ;Molecular Cancer Therapeutics. 2021 Sep 13
• 9 citations
  A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.
  Chul Kim, Stephen V. Liu, Jennifer Crawford, Tisdrey Torres, Vincent Chen, Jillian Thompson, Ming Tan, Giuseppe Esposito, Deepa S. Subramaniam, Giuseppe Giaccone> ;Frontiers in Oncology. 2021 Sep 8
• 2 citations
  Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)
  Misako Nagasaka, Mohammad Fahad Bin Asad, Mohammed Najeeb Al Hallak, Hafiz Uddin, Ammar Sukari, Yasmine Baca, Joanne Xiu, Dan Magee, Hirva Mamdani, Dipesh Uprety, Chul...> ;Lung Cancer. 2021 Aug 27
• 4 citations
  Safety and Efficacy of First-Line Pembrolizumab in Black Patients with Metastatic Non-Small Cell Lung Cancer.
  Monica Peravali, Jaeil Ahn, Kevin Chen, Suman Rao, Irina Veytsman, Stephen V. Liu, Chul Kim> ;The Oncologist. 2021 Aug 1
• 13 citations
  Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
  , , , , , , , , , , , , , , , , , , , , , > ;Cancers. 2021 Jul 3
• 6 citations
  Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report.
  Paul Sackstein, Jacob Zaemes, Chul Kim> ;Journal for Immunotherapy of Cancer. 2021 Jul 1
• 4 citations
  Divergent RET- and BRAF-Mediated Resistance to Osimertinib in EGFR-Mutant NSCLC: A Case Report
  Muneeb Rehman, Chul Kim, Joshua E. Reuss, Lesli A. Kiedrowski, Ravin J. Garg, Stephen V. Liu> ;JCO Precision Oncology. 2021 Jun 4
• Join now to see all